-
About UsBPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
-
S&TInternational-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
-
Research and DevelopmentChina has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
-
BlogIntegrating industry-related media coverage as well as the company’s various activities and updates.
-
Join UsBoasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
-
Are "EGF vaccines" for treating lung cancer available domestically, or are there any ongoing clinical trials for them?
Category:
Patient Consultation
Author:
Source:
Release date:
2016-01-12
On November 29, 2011, China Central News Channel's International News reported the groundbreaking development of Cuba’s CIMA vax-EGF lung cancer vaccine, created by experts at Cuba’s Center for Molecular Immunology. Clinical trials conducted in Cuba, the UK, Canada, and Malaysia involving over 800 patients with advanced-stage lung cancer demonstrated that the vaccine significantly improved survival rates. Currently, the vaccine is in Phase III clinical trials in Cuba, while domestically, no vax-EGF lung cancer vaccine is yet available for sale or undergoing clinical testing.
If clinical trials for this vaccine are conducted domestically, BIOTECH PHARMACEUTICAL CO., LTD will announce the news immediately—stay tuned!
Related News
Biotech pharmaceutical co., Ltd
Email: cooperation@biotechplc.com
BD Dept: bd@biotechplc.com
Address：NO.2 Rongjing East Street, Beijing Economic and Technological Development Area, Beijing 100176
Biotech pharmaceutical co., Ltd
E-mail：
Tel：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： BIOTECH PHARMACEUTICAL CO., LTD
表单验证提示文本： Content cannot be empty!
循环体没有内容时： Sorry, no matching items were found.
CSS / JS 文件放置地